Business Wire

GeoSpock Strikes Commercial Partnership with Smart Cambridge to Further Smart City Ambitions

5.3.2019 13:01:00 EET | Business Wire | Press release

Share

GeoSpock® – the extreme-scale spatial big data company that provides analytics, builds insight, and enables predictions across space and time – today announced its commercial alliance with the Greater Cambridge Partnership, the first public sector organisation to sign up to its G-Cloud initiative.

The initiative will see the Smart Cambridge team utilise GeoSpock’s spatial big data platform – which processes data at speed and scale, generating spatial and temporal insights – to develop a data-first smart city strategy. The initiative will democratise data from physical assets to enable better decision making by providing greater contextual understanding and delivering a single origin of data truth.

This will support the work of the Greater Cambridge Partnership and bring tangible benefits to the lives of residents, businesses and visitors, including improvements to traffic flow and citizen mobility, as well as to environmental initiatives and the future planning of the city.

By unlocking siloed data within the region, GeoSpock will provide a common data transformation Platform as a Service, run on Amazon AWS Cloud, on which Smart Cambridge can share information for the benefit of staff and third-party organisations working on urban innovation projects.

This will enable local councils to better plan for the future development of new homes and businesses, as well as for public utilities and infrastructure, such as electric charging points, smart roads, autonomous bus routes, and smart energy networks. Predictive analysis and real-time management of people’s needs will also allow councils to plan resourcing ahead of time and improve sustainability.

Richard Baker, CEO of GeoSpock, comments: “Cambridge is one of the leading and most progressive smart cities in the UK, and we’re thrilled to be embarking on this partnership to showcase how GeoSpock’s technology can develop the city’s future smart ecosystem. We are passionate about delivering better contextual understanding to enable more informed decisions for the benefit of the citizens, visitors, and businesses of the region – particularly as the area is also home to GeoSpock’s headquarters.”

Claire Ruskin, Executive Board Member for the Greater Cambridge Partnership, and CEO of Cambridge Network, comments: “GeoSpock’s spatial big data platform is extremely impressive and I’m eager to see the successes we can achieve together. This is an exciting new relationship for the Greater Cambridge Partnership that will provide a digital platform to support the transport infrastructure investments taking place in our region. By bringing together data that is currently locked in separate silos, Smart Cambridge will be able to input into decisions that enhance people’s access between homes and daily destinations, optimise traffic flow, and reduce CO 2 emissions.”

GeoSpock aims to become the de facto processing engine at the heart of next-generation infrastructure, including smart cities and the Internet of Everything (IoE), as well as powering future mobility applications, including the management of autonomous vehicle fleets. The company’s revolutionary data engine analyses extreme amounts of contextual data in sub-second response time.

<ENDS>

About GeoSpock

GeoSpock® provides analytics, builds insight, and enables predictions across space and time. Its proprietary spatial big data platform visualises extreme amounts of contextual data in milliseconds and its architecture has the ability to analyse trillions of geospatial and temporal data points in sub-second response time. Conceived by Dr Steve Marsh while reading for his PhD in Computer Science at Cambridge University and founded as a business in 2013, GeoSpock is the future of big data management, providing extreme-scale, high volume-ingest, ease of use, and interactive results. Learn more at www.geospock.com or on Twitter @GeoSpock

About Smart Cambridge

The work of Smart Cambridge is supported by the Connecting Cambridgeshire programme, led by Cambridgeshire County Council, with investment from the Greater Cambridge Partnership. www.connectingcambridgeshire.co.uk/smartcambridge

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media contact for GeoSpock
sarah@geospockpr.com
+44 203 642 1124

Media contact for Smart Cambridge
Dan Clarke, Strategy and Partnerships Manager
Daniel.clarke@cambridgeshire.gov.uk

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Leaders of Dubai-Based Unicorns Hail City as Global Innovation Hub Shaping Future Technology and Driving the Digital Economy20.4.2026 16:08:00 EEST | Press release

Leaders of Dubai-based unicorn companies have reaffirmed the emirate’s status as a global hub for digital innovation and technology-led growth. The senior executives highlighted Dubai’s forward-looking regulatory environment, advanced infrastructure, and ability to attract international talent as key factors strengthening its appeal for high-growth digital businesses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420503062/en/ Leaders of Dubai-based unicorns hail city as global innovation hub shaping future technology and driving the digital economy (Photo: AETOSWire) They noted that Dubai has evolved into a strategic launchpad for ambitious companies, offering an agile business environment that supports innovation and enables expansion into regional and international markets. The business leaders also praised the strong alignment between the public and private sectors within Dubai’s digital ecosystem, supported by Dubai

Capcom’s All-New IP PRAGMATA Surpasses One Million Units Sold in Two Days!20.4.2026 16:00:00 EEST | Press release

Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of PRAGMATA, the company’s all-new IP released on April 17, 2026*, have surpassed one million units. PRAGMATA is a science-fiction action-adventure game that depicts the journey of Hugh Williams and Diana, an android girl, in a near-future lunar world. A completely new IP, PRAGMATA was developed primarily by a team of younger Capcom developers, who created an innovative gameplay experience by fusing action gameplay with puzzle elements set within a distinctive world ruled over by artificial intelligence. In the absence of an established fan base or preexisting brand recognition, Capcom implemented a range of marketing initiatives—beginning with the early release of a playable demo—to communicate the unique features of the game to a wider audience. In addition, in line with the company’s multi-platform strategy, Capcom broadened the title’s availability by adding support for Nintendo Switch™ 2 at an early stage. As a res

Capcom’s All-New IP PRAGMATA Surpasses One Million Units Sold in Two Days!20.4.2026 16:00:00 EEST | Press release

Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of PRAGMATA, the company’s all-new IP released on April 17, 2026*, have surpassed one million units. PRAGMATA is a science-fiction action-adventure game that depicts the journey of Hugh Williams and Diana, an android girl, in a near-future lunar world. A completely new IP, PRAGMATA was developed primarily by a team of younger Capcom developers, who created an innovative gameplay experience by fusing action gameplay with puzzle elements set within a distinctive world ruled over by artificial intelligence. In the absence of an established fan base or preexisting brand recognition, Capcom implemented a range of marketing initiatives—beginning with the early release of a playable demo—to communicate the unique features of the game to a wider audience. In addition, in line with the company’s multi-platform strategy, Capcom broadened the title’s availability by adding support for Nintendo Switch™ 2 at an early stage. As a res

Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer20.4.2026 15:30:00 EEST | Press release

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123). The designation is for the treatment of adult patients with CCNE1 amplified, or a deleterious mutation in either FBXW7 or PPP2R1A, platinum-resistant/refractory ovarian cancer. The FDA’s Fast Track program is designed to facilitate the development and expedite the review of new drugs intended to treat serious conditions and fill an unmet medical need. Programs granted Fast Track designation benefit from more frequent communication with the FDA and, if relevant criteria are met, may be eligible for Priority Review and Accelerated Approval of a New Drug Application (NDA). Momentum Following AACR O

Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer20.4.2026 15:30:00 EEST | Press release

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123). The designation is for the treatment of adult patients with CCNE1 amplified, or a deleterious mutation in either FBXW7 or PPP2R1A, platinum-resistant/refractory ovarian cancer. The FDA’s Fast Track program is designed to facilitate the development and expedite the review of new drugs intended to treat serious conditions and fill an unmet medical need. Programs granted Fast Track designation benefit from more frequent communication with the FDA and, if relevant criteria are met, may be eligible for Priority Review and Accelerated Approval of a New Drug Application (NDA). Momentum Following AACR O

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye